AVEO - AVEO Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue2,51519,02418,123
Cost of Revenue---
Gross Profit2,51519,02418,123
Operating Expenses
Research Development23,70312,87538,254
Selling General and Administrative8,20514,21718,589
Non Recurring-4,35811,729
Total Operating Expenses---
Operating Income or Loss-29,393-12,426-50,449
Income from Continuing Operations
Total Other Income/Expenses Net4,556-28966
Earnings Before Interest and Taxes-24,837-12,715-50,383
Interest Expense1,9492,2862,356
Income Before Tax-26,786-15,001-52,739
Income Tax Expense101--
Minority Interest---
Net Income From Continuing Ops-26,887-15,001-52,739
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-26,887-15,001-52,739
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-26,887-15,001-52,739